Actionable news
0
All posts from Actionable news
Actionable news in ACOR: Acorda Therapeutics, Inc.,

Acorda Therapeutics to Present at Two Investor Conferences in May

ARDSLEY, N.Y., Apr 29, 2016 (BUSINESS WIRE) -- Acorda Therapeutics, Inc. (Nasdaq:ACOR) announced that the Company will present at two investor conferences during May.

Deutsche Bank 41 [st] Annual Health Care Conference

Michael Rogers, Chief Financial Officer, and Rick Batycky, Chief Technology Officer, will present at the Deutsche Bank 41 [st] Annual Health Care Conference in Boston on Wednesday, May 4 at 2:10 pm ET. A live audio webcast of the presentation can be accessed under “Investor Events” in the Investor section of the Acorda website or you may use the link:

Bank of America Merrill Lynch 2016 Health Care Conference

Michael Rogers, Chief Financial Officer and Andrew Blight, Chief Scientific Officer, will present at the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas on Wednesday, May 11 at 8:00 am PT. A live audio webcast of the presentation can be accessed under “Investor Events” in the Investor section of the Acorda website or you may use the link:

About Acorda Therapeutics

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson’s disease, epilepsy, post-stroke walking deficits, migraine, and multiple...


More